Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stroke

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 110 articles:
HTML format
Text format



Single Articles


    August 2018
  1. O'SHAUGHNESSY MM, Liu S, Montez-Rath ME, Lafayette RA, et al
    Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
    Eur Heart J. 2018 Aug 2. pii: 5064050. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  2. FRIEDRICH S, Ng PY, Platzbecker K, Burns SM, et al
    Patent foramen ovale and long-term risk of ischaemic stroke after surgery.
    Eur Heart J. 2018 Jul 17. pii: 5055460. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  3. RIDKER PM
    Interleukin-1 inhibition and ischaemic stroke: has the time for a major outcomes trial arrived?
    Eur Heart J. 2018 Jun 27. pii: 5046018. doi: 10.1093.
    PubMed     Text format    


    May 2018
  4. YANG H, Nassif M, Khairy P, de Groot JR, et al
    Cardiac diagnostic work-up of ischaemic stroke.
    Eur Heart J. 2018;39:1851-1860.
    PubMed     Text format     Abstract available


  5. LIBERALE L, Diaz-Canestro C, Bonetti NR, Paneni F, et al
    Post-ischaemic administration of the murine Canakinumab-surrogate antibody improves outcome in experimental stroke.
    Eur Heart J. 2018 May 16. pii: 4996878. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  6. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. ANDREOTTI F, Navarese EP, Crea F
    Prolonged endogenous fibrinolysis predicts reduced survival after acute coronary syndromes.
    Eur Heart J. 2018;39:1086-1088.
    PubMed     Text format    


    March 2018
  8. LANDMESSER U, Chapman MJ, Stock JK, Amarenco P, et al
    New prospects for PCSK9 inhibition?
    Eur Heart J. 2018 Mar 22. pii: 4951530. doi: 10.1093.
    PubMed     Text format    


    February 2018
  9. FADINI GP, Cosentino F
    Diabetes and ischaemic stroke: a deadly association.
    Eur Heart J. 2018 Feb 9. pii: 4846897. doi: 10.1093.
    PubMed     Text format    


  10. ECHOUFFO-TCHEUGUI JB, Xu H, Matsouaka RA, Xian Y, et al
    Diabetes and long-term outcomes of ischaemic stroke: findings from Get With The Guidelines-Stroke.
    Eur Heart J. 2018 Feb 9. pii: 4846898. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. LANCELLOTTI P, Galderisi M
    Prediction of ischaemic stroke in non-valvular atrial fibrillation if advanced echocardiography plays the game.
    Eur Heart J. 2018 Feb 9. pii: 4847811. doi: 10.1093.
    PubMed     Text format    


    January 2018
  12. BERGMARK BA, Scirica BM, Steg PG, Fanola CL, et al
    Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
    Eur Heart J. 2018 Jan 31. pii: 4831245. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  13. LEUNG M, van Rosendael PJ, Abou R, Ajmone Marsan N, et al
    Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry.
    Eur Heart J. 2017 Dec 28. pii: 4781364. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  14. DARMON A, Bhatt DL, Elbez Y, Aboyans V, et al
    External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry.
    Eur Heart J. 2017 Nov 23. pii: 4656148. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. STAERK L, Fosbol EL, Lamberts M, Bonde AN, et al
    Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2017 Nov 18. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  16. LANDMESSER U, Chapman MJ, Stock JK, Amarenco P, et al
    2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.
    Eur Heart J. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format    


  17. CALIFF RM
    Finding ideal blood pressure targets in ischaemic stroke: prospective insight or retrospective guesswork?
    Eur Heart J. 2017;38:2836-2837.
    PubMed     Text format    


  18. BANGALORE S, Schwamm L, Smith EE, Hellkamp AS, et al
    Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke.
    Eur Heart J. 2017;38:2827-2835.
    PubMed     Text format     Abstract available


    September 2017
  19. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    PubMed     Text format     Abstract available


    August 2017
  20. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. WIDIMSKY P, Doehner W, Diener HC, Van Gelder IC, et al
    The role of cardiologists in stroke prevention and treatment: position paper of the European Society of Cardiology Council on Stroke.
    Eur Heart J. 2017 Aug 28. doi: 10.1093.
    PubMed     Text format    


  22. IBANEZ B, James S, Agewall S, Antunes MJ, et al
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format    


  23. ABOYANS V, Bjorck M, Brodmann M, Collet JP, et al
    Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Societ
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format    


    July 2017
  24. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
    Thrombo-embolic prevention after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
    Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
    Eur Heart J. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  26. VIDAL-PETIOT E, Stebbins A, Chiswell K, Ardissino D, et al
    Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial.
    Eur Heart J. 2017 May 27. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  27. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. CAVALCANTE R, Sotomi Y, Mancone M, Whan Lee C, et al
    Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
    Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Eur Heart J. 2017;38:1069-1080.
    PubMed     Text format     Abstract available


  30. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Text format     Abstract available


    March 2017
  31. VOLLEMA EM, Kong WK, Katsanos S, Kamperidis V, et al
    Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. LI XS, Obeid S, Klingenberg R, Gencer B, et al
    Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Eur Heart J. 2017;38:814-824.
    PubMed     Text format     Abstract available


  33. ABDUL-RAHIM AH, Perez AC, MacIsaac RL, Jhund PS, et al
    Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
    Eur Heart J. 2017;38:742-750.
    PubMed     Text format     Abstract available


  34. VAN GELDER IC, Healey JS, Crijns HJ, Wang J, et al
    Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.
    Eur Heart J. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  35. PASEA L, Chung SC, Pujades-Rodriguez M, Moayyeri A, et al
    Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.
    Eur Heart J. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. MAZZOLAI L, Aboyans V, Ageno W, Agnelli G, et al
    Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function.
    Eur Heart J. 2017 Feb 17. doi: 10.1093.
    PubMed     Text format    


  37. CIMATO TR
    Persistent stem cell-driven inflammation in patients with prior MI and stroke.
    Eur Heart J. 2017;38:433-435.
    PubMed     Text format    


    January 2017
  38. GADSBOLL K, Staerk L, Fosbol EL, Sindet-Pedersen C, et al
    Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.
    Eur Heart J. 2017 Jan 21. pii: ehw658. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. RENOUX C, Coulombe J, Suissa S
    Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study.
    Eur Heart J. 2017 Jan 10. pii: ehw613. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. REINER MF, Breitenstein A, Holy EW, Glanzmann M, et al
    Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium.
    Eur Heart J. 2017 Jan 8. pii: ehw578. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. FANOLA CL, Giugliano RP, Ruff CT, Trevisan M, et al
    A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.
    Eur Heart J. 2017 Jan 6. pii: ehw565. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. DE CARLO M, Mazzolai L, Bossone E, Brodmann M, et al
    The year in cardiology 2016: peripheral circulation.
    Eur Heart J. 2017 Jan 2. pii: ehw643. doi: 10.1093.
    PubMed     Text format    


  43. GAL P, Marrouche NF
    Magnetic resonance imaging of atrial fibrosis: redefining atrial fibrillation to a syndrome.
    Eur Heart J. 2017;38:14-19.
    PubMed     Text format     Abstract available


    November 2016
  44. YANG H, Nassif M, Khairy P, de Groot JR, et al
    Cardiac diagnostic work-up of ischaemic stroke.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    October 2016
  45. TARANTINI G, Mojoli M, Urena M, Vahanian A, et al
    Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  46. GUDBJARTSSON DF, Holm H, Sulem P, Masson G, et al
    A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  47. STAERK L, Fosbol EL, Lip GY, Lamberts M, et al
    Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available



  48. Racing against time in acute ischaemic stroke treatment.
    Eur Heart J. 2016;37:2856-2857.
    PubMed     Text format    


    September 2016
  49. PICCINI JP, Sievert H, Patel MR
    Left atrial appendage occlusion: rationale, evidence, devices, and patient selection.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    August 2016
  50. LUSCHER TF
    Atrial fibrillation and stroke: risk factors, anticoagulation, and left atrial appendage occluders.
    Eur Heart J. 2016;37:2443-5.
    PubMed     Text format    


    June 2016
  51. BASSAND JP, Accetta G, Camm AJ, Cools F, et al
    Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  52. FERREIRA JP, Girerd N, Alshalash S, Konstam MA, et al
    Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    April 2016
  53. SANDHU RK, Ezekowitz J, Andersson U, Alexander JH, et al
    The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  54. NIELSEN JC, Gerdes JC
    Does catheter ablation reduce mortality and stroke in patients with atrial fibrillation? Patient selection or causality?
    Eur Heart J. 2016.
    PubMed     Text format    


    March 2016
  55. CAIRNS JA
    The search for the ideal atrial fibrillation stroke risk prediction schema: is ATRIA a contender?
    Eur Heart J. 2016.
    PubMed     Text format    


  56. LUSCHER TF, Sudano I
    SPRINT: the race for optimal blood pressure control.
    Eur Heart J. 2016;37:937-41.
    PubMed     Text format    


  57. FRIBERG L, Tabrizi F, Englund A
    Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  58. FOX KA
    CardioPulse: Anticoagulants reduce risk of death in atrialfibrillation patients by 38%.
    Eur Heart J. 2016;37:860-1.
    PubMed     Text format    


  59. SVENSSON T, Inoue M, Sawada N, Yamagishi K, et al
    Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study.
    Eur Heart J. 2016;37:890-9.
    PubMed     Text format     Abstract available


  60. STOEKENBROEK RM, Boekholdt SM, Luben R, Hovingh GK, et al
    Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.
    Eur Heart J. 2016;37:880-9.
    PubMed     Text format     Abstract available


  61. RANTHE MF, Diaz LJ, Behrens I, Bundgaard H, et al
    Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort studydagger.
    Eur Heart J. 2016;37:900-7.
    PubMed     Text format     Abstract available


  62. WAKSMAN R, Rogers T
    CardioPulse: Transcatheter aortic valve replacement.The American perspective on transcatheter aortic valve replacement.
    Eur Heart J. 2016;37:797-9.
    PubMed     Text format    


  63. ASPBERG S, Chang Y, Atterman A, Bottai M, et al
    Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    February 2016
  64. HIJAZI Z, Lindback J, Alexander JH, Hanna M, et al
    The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  65. GANESAN AN, Chew DP, Hartshorne T, Selvanayagam JB, et al
    The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  66. TRUCHANOWICZ E, Kirchhof P
    CardioPulse: New perspectives for stroke prevention in atrial fibrillation.
    Eur Heart J. 2016;37:583-4.
    PubMed     Text format    


  67. STEFFEL J, Jais P, Hindricks G
    The year in cardiology 2015: arrhythmias and device therapy.
    Eur Heart J. 2016;37:587-93.
    PubMed     Text format    


  68. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  69. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    January 2016
  70. IUNG B, Rahimtoola SH, Vahanian A
    The year in cardiology 2015: valvular heart disease.
    Eur Heart J. 2016.
    PubMed     Text format    


    November 2015
  71. MANCIA G, Kjeldsen SE, Zappe DH, Holzhauer B, et al
    Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  72. HAMM CW, Arsalan M, Mack MJ
    The future of transcatheter aortic valve implantation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    October 2015
  73. WIDIMSKY P, Hopkins LN
    Catheter-based interventions for acute ischaemic stroke.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    September 2015
  74. O'BRIEN EC, Simon DN, Thomas LE, Hylek EM, et al
    The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  75. KOTECHA D, Piccini JP
    Atrial fibrillation in heart failure: what should we do?
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  76. SKOLOUDIK D, Kuliha M, Hrbac T, Jonszta T, et al
    Sonolysis in Prevention of Brain Infarction During Carotid Endarterectomy and Stenting (SONOBUSTER): a randomized, controlled trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  77. LUSCHER TF
    Stroke: cardiac causes and their management.
    Eur Heart J. 2015;36:2339-41.
    PubMed     Text format    


  78. KENT DM, Dahabreh IJ, Ruthazer R, Furlan AJ, et al
    Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis.
    Eur Heart J. 2015;36:2381-9.
    PubMed     Text format     Abstract available


  79. SARDAR P, Chatterjee S, Giri J, Kundu A, et al
    Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials.
    Eur Heart J. 2015;36:2373-80.
    PubMed     Text format     Abstract available


  80. VINEREANU D, Stevens SR, Alexander JH, Al-Khatib SM, et al
    Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  81. LIP GY
    The CHA2DS2-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history.
    Eur Heart J. 2015.
    PubMed     Text format    


  82. LIP GY, Lane DA
    Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors.
    Eur Heart J. 2015.
    PubMed     Text format    


  83. CAMM AJ, Amarenco P, Haas S, Hess S, et al
    XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    August 2015
  84. BARBASH IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, et al
    Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  85. SHARMA R, Oni OA, Gupta K, Chen G, et al
    Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  86. TAYLOR J
    Hand grip strength predicts myocardial infarction and stroke.
    Eur Heart J. 2015;36:1845.
    PubMed     Text format    


    July 2015
  87. STONE GW, Adams DH, Abraham WT, Kappetein AP, et al
    Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  88. DENEGRI A, Pedrazzini GB, Moccetti T, Moccetti M, et al
    Calcification of the mitral valve complicated by embolization and subsequent ischemic stroke with haemorrhagic transformation.
    Eur Heart J. 2015.
    PubMed     Text format    


  89. LUSCHER TF MD FESC
    Novel risk markers and mediators in coronary disease and stroke.
    Eur Heart J. 2015;36:1557-1559.
    PubMed     Text format    


  90. JAMES S
    Stroke: a rare but devastating procedural complication of PCI.
    Eur Heart J. 2015;36:1571-2.
    PubMed     Text format    


  91. VOLPE M, Paneni F
    Shooting vascular oxidative stress: new hopes for stroke patients?
    Eur Heart J. 2015;36:1573-5.
    PubMed     Text format    


  92. SPESCHA RD, Klohs J, Semerano A, Giacalone G, et al
    Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke.
    Eur Heart J. 2015;36:1590-600.
    PubMed     Text format     Abstract available


    June 2015
  93. JOLLY SS, Cairns JA, Yusuf S, Meeks B, et al
    Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  94. POKORNEY SD, Granger CB
    Should patients on vitamin K antagonists be treated differently?
    Eur Heart J. 2015;36:1431-3.
    PubMed     Text format    


  95. O'DONOGHUE ML, Ruff CT, Giugliano RP, Murphy SA, et al
    Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillationdagger.
    Eur Heart J. 2015;36:1470-7.
    PubMed     Text format     Abstract available


  96. LANZER P, Widimsky P
    Ischaemic stroke and ST-segment elevation myocardial infarction: fast-track single-stop approach.
    Eur Heart J. 2015.
    PubMed     Text format    


    May 2015
  97. COSTA F, Vranckx P, Leonardi S, Moscarella E, et al
    Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment A
    Eur Heart J. 2015;36:1242-51.
    PubMed     Text format     Abstract available


  98. SCHULZ-SCHUPKE S, Byrne RA, Ten Berg JM, Neumann FJ, et al
    ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.
    Eur Heart J. 2015;36:1252-63.
    PubMed     Text format     Abstract available


  99. PHILIPPART R, Brunet-Bernard A, Clementy N, Bourguignon T, et al
    Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  100. JERNBERG T, Hasvold P, Henriksson M, Hjelm H, et al
    Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective.
    Eur Heart J. 2015;36:1163-70.
    PubMed     Text format     Abstract available


  101. STEFFEL J, Giugliano RP, Braunwald E, Murphy SA, et al
    Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  102. KARANASOS A, Van Mieghem NM, Regar E, Daemen J, et al
    Serial imaging observations of vascular healing in a denervation-induced renal artery dissection.
    Eur Heart J. 2015;36:1040.
    PubMed     Text format    


  103. VAN DER DONCKT C, Van Herck JL, Schrijvers DM, Vanhoutte G, et al
    Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death.
    Eur Heart J. 2015;36:1049-58.
    PubMed     Text format     Abstract available


    April 2015
  104. KWOK CS, Kontopantelis E, Myint PK, Zaman A, et al
    Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    March 2015
  105. LANZER P
    CardioPulse: STEMI and stroke: distant cousins at best.
    Eur Heart J. 2015;36:590.
    PubMed     Text format    


    February 2015
  106. ALIOT E, Brandes A, Eckardt L, Elvan A, et al
    The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Eur Heart J. 2015;36:255-6.
    PubMed     Text format    


  107. HEIDBUCHEL H, Hindricks G
    The year in cardiology 2014: arrhythmias and device therapy.
    Eur Heart J. 2015;36:270-8.
    PubMed     Text format     Abstract available


    January 2015
  108. CREMONESI A, Castriota F, Secco GG, Macdonald S, et al
    Carotid artery stenting: an update.
    Eur Heart J. 2015;36:13-21.
    PubMed     Text format     Abstract available


    December 2014
  109. TANIWAKI M, Windecker S, Raber L
    Silent myocardial infarction and stroke: findings of multimodality imaging.
    Eur Heart J. 2014.
    PubMed     Text format    


  110. HELD C, Hylek EM, Alexander JH, Hanna M, et al
    Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
    Eur Heart J. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: